Literature DB >> 2938856

The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.

P S Mach, H Brouilhet, B Amor.   

Abstract

The capacity of D-Penicillamine (DP) to induce or to potentiate the production of antinuclear antibodies (ANA), detected by immunofluorescence (IF), was investigated in vitro, using peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) and normal individuals. Except in one patient with SLE, DP did not enhance ANA synthesis when using unseparated PBMC. In contrast, when B cells were cocultured with irradiated T cells or irradiated enriched T4+ subset, DP induced or potentiated the production of ANA. These results indicate that DP acts by stimulating T4+ helper cells to promote ANA synthesis in the absence of radio-sensitive suppressor T cell function contained within the T4+ population.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938856      PMCID: PMC1577361     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  [Anti-DNA antibodies; results of a new method of detection using the fluorescent antibody technic].

Authors:  M F Kahn; A P Peltier; T Haim; M Marcheteau; S de Sèze
Journal:  Rev Rhum Mal Osteoartic       Date:  1973-06

2.  [Lupoid syndrome due to D-penicillamine associated with Wilson's disease: clinical study of a case].

Authors:  B Caille; J P Harpey; C Lejeune; Y Sudre; R Turpin
Journal:  Ann Med Interne (Paris)       Date:  1971-02

3.  Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation.

Authors:  Y Thomas; J Sosman; O Irigoyen; S M Friedman; P C Kung; G Goldstein; L Chess
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

4.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

5.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

6.  Genetic control of antinuclear antibodies in mice inoculated with the moloney leukaemia virus.

Authors:  D Piatier; P Debre; P S Mach; S Gisselbrecht
Journal:  J Immunogenet       Date:  1981-06

7.  Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

8.  Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities.

Authors:  P S Mach; D Piatier; A Le Go; F Delbarre
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

9.  Hidden anti-nuclear antibodies in rheumatic diseases.

Authors:  P S Mach; D Piatier; A Le Go; F Delbarre
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

10.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P H Wooley; J Griffin; G S Panayi; J R Batchelor; K I Welsh; T J Gibson
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.